India's Sun Pharmaceutical Industries Ltd. is recalling four lots of injectible Norcuron from hospitals due to the presence of extremely small glass particles in the medicine.
Norcuron, or vecuronium bromide, is used as part of general anesthesia to relax muscles before surgery or mechanical ventilation.
The company has recalled three lots of the medication in 10-milligram dosage and one lot in the 20-milligram dosage.
Injecting glass particles with other medication can lead to irritation and swelling and in extreme cases may cause blockage and clotting in blood vessels, which can be life-threatening.
The company said it has not received any reports of adverse events related to the recall, which is being conducted with the knowledge of the U.S. Food and Drug Administration.